Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 34Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia, Myeloid, Chronic-Phase 27Lymphoma 24Leukemia, Myeloid, Acute 24Leukemia, Myeloid, Accelerated Phase 24Burkitt Lymphoma 22Myeloproliferative Disorders 20Blast Crisis 20Multiple Myeloma 19Lymphoma, Follicular 19Leukemia, Lymphocytic, Chronic, B-Cell 19Neoplasms, Plasma Cell 18Lymphoma, Non-Hodgkin 18Lymphoma, Large-Cell, Immunoblastic 18Lymphoma, Large B-Cell, Diffuse 18Lymphoma, B-Cell, Marginal Zone 18Lymphoma, Mantle-Cell 17Leukemia, Myelomonocytic, Chronic 17Dendritic Cell Sarcoma, Interdigitating 17Hodgkin Disease 16Graft vs Host Disease 16Congenital Abnormalities 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Anemia, Refractory, with Excess of Blasts 15Recurrence 14Primary Myelofibrosis 13Myelodysplastic-Myeloproliferative Diseases 13Lymphoma, T-Cell, Cutaneous 11

Interventions

Radiotherapy 1Methylprednisolone 1Melphalan 1Imatinib Mesylate 1Fentanyl 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Methylprednisolone × Myeloid × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡